Search Results | Cancer Research | American Association for Cancer Research

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer.

Ritu Arora, Bernard D. Gary, Steven McClellan, Yaguang Xi, Gary Piazza, Eddie Reed, Laurie Owen, Windy Dean-Colomb

Cancer Res (2013) 73 (8_Supplement): 5571.

DOI: https://doi.org/10.1158/1538-7445.AM2013-5571

Published: 15 April 2013

View article

Journal Articles

Abstract LB-223: A specific Isoform of Gli1 binds the promoter region of c-fos in A2780-CP70 human ovarian cancer cells.

Lauren Amable, Kenji Kudo, Elaine Gavin, Jason Fain, Eddie Reed

Cancer Res (2013) 73 (8_Supplement): LB-223.

DOI: https://doi.org/10.1158/1538-7445.AM2013-LB-223

Published: 15 April 2013

View article

Journal Articles

Abstract 771: Changes in the subcellular pharmacology of cisplatin, in response to treatment of cells with an anti-Gli1 shRNA

Jason C. Fain, Lauren Amable, Elaine Gavin, Eddie Reed

Cancer Res (2012) 72 (8_Supplement): 771.

DOI: https://doi.org/10.1158/1538-7445.AM2012-771

Published: 15 April 2012

View article

Journal Articles

Abstract 605: Olive polyphenol, hydroxytyrosol, exerts anti-tumor effects in prostate cancer cells by targeting Akt, STAT3 and AR signaling

Arun Bhardwaj, Seema Singh, Sanjeev K. Srivastava, Sumit Arora, Eddie Reed, Ajay P. Singh

Cancer Res (2012) 72 (8_Supplement): 605.

DOI: https://doi.org/10.1158/1538-7445.AM2012-605

Published: 15 April 2012

View article

Journal Articles

Abstract 834: Inhibition of Gli1 results in altered c-jun activation, inhibition of cisplatin-induced up-regulation of ERCC1, XPD, and XRCC1, and inhibition of platinum-DNA adduct repair

Elaine J. Gavin, Kenji Kudo, Shamik Das, Lauren Amable, Lalita A. Shevde, Eddie Reed

Cancer Res (2012) 72 (8_Supplement): 834.

DOI: https://doi.org/10.1158/1538-7445.AM2012-834

Published: 15 April 2012

View article

Journal Articles

Abstract 3991: Protein phosphatase 2A (PP2A) downregulation is associated with androgen-independent and aggressive phenotypes in prostate cancer

Arun Bhardwaj, Sanjeev K. Srivastava, Seema Singh, Sumit Arora, Richard E. Honkanen, William E. Grizzle, Eddie Reed, Ajay P. Singh

Cancer Res (2012) 72 (8_Supplement): 3991.

DOI: https://doi.org/10.1158/1538-7445.AM2012-3991

Published: 15 April 2012

View article

Journal Articles

Abstract 5613: A specific isoform of Gli1 binds the Gli-binding site of the c-jun and c-fos promoters

Lauren Amable, Elaine Gavin, Wesley Denny, Erhong Meng, Rodney P. Rocconi, Eddie Reed

Cancer Res (2012) 72 (8_Supplement): 5613.

DOI: https://doi.org/10.1158/1538-7445.AM2012-5613

Published: 15 April 2012

View article

Journal Articles

Abstract 3406: Understanding molecular pathway differences between ovarian cancer stem cells (OCSC) and non-ovarian cancer stem cells (non-OCSC) leads to the Hedgehog pathway as a common thread

Erhong P. Meng, Lalita Shevde, Eddie Reed, Rodney P. Rocconi

Cancer Res (2011) 71 (8_Supplement): 3406.

DOI: https://doi.org/10.1158/1538-7445.AM2011-3406

Published: 15 April 2011

View article

Journal Articles

Abstract 249: Inhibition of protein phosphatase 2A supports androgen-independent growth of prostate cancer cells

Arun Bhardwaj, Seema Singh, Sanjeev K. Srivastava, Richard E. Honkanen, Eddie Reed, Ajay P. Singh

Cancer Res (2011) 71 (8_Supplement): 249.

DOI: https://doi.org/10.1158/1538-7445.AM2011-249

Published: 15 April 2011

View article

Journal Articles

Abstract 2156: c-Myb promotes growth, invasion and androgen-independence of prostate cancer cells

Sanjeev K. Srivastava, Arun Bhardwaj, Seema Singh, Eddie Reed, William Grizzle, Ajay P. Singh

Cancer Res (2011) 71 (8_Supplement): 2156.

DOI: https://doi.org/10.1158/1538-7445.AM2011-2156

Published: 15 April 2011

View article

Journal Articles

Abstract LB-281: Inhibition of Hedgehog results in altered regulation of c-jun and of ERCC1 in cisplatin-resistant A2780-CP70 human ovarian cancer cells

Kenji Kudo, Elaine Gavin, Shamik Das, Wesley Denny, Martine Jasmin, Lalita Shevde-Samant, Eddie Reed

Cancer Res (2010) 70 (8_Supplement): LB-281.

DOI: https://doi.org/10.1158/1538-7445.AM10-LB-281

Published: 15 April 2010

View article

Journal Articles

A Gynecologic Oncology Group Study of Platinum-DNA Adducts and Excision Repair Cross-Complementation Group 1 Expression in Optimal, Stage III Epithelial Ovarian Cancer Treated with Platinum-Taxane Chemotherapy

Kathleen M. Darcy, Chunqiao Tian, Eddie Reed

Cancer Res (2007) 67 (9): 4474–4481.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-4076

Published: 04 May 2007

View article

Journal Articles

Variant DNA repair genes occur infrequently in African Americans: Implications for different clinic response to platinum chemotherapy

Rui Gao, Douglas Price, Eddie Reed, William Figg

Cancer Res (2007) 67 (9_Supplement): 735.

Published: 01 May 2007

View article

Journal Articles

Fanconi anemia D2 protein confers chemoresistance and contributes to S phase cell cycle arrest in response to the anticancer agent, irofulven

Yutian Wang, Timothy Wiltshire, Jamie Senft, Sharon L. Wenger, Emily S. Van Laar, Shannon Wadman, Stephen J. Waters, Eddie Reed, Weixin Wang

Cancer Res (2006) 66 (8_Supplement): 123–124.

Published: 15 April 2006

View article

Journal Articles

MZF1 possesses a repressively regulatory function in ERCC1 expression

Qing-Wu Yan, Eddie Reed, Xiao-Song Zhong, Keith Thornton, Yi Guo, Jing Jie Yu

Cancer Res (2006) 66 (8_Supplement): 402.

Published: 15 April 2006

View article

Journal Articles

Elemene, a novel plant anticancer drug, enhances cisplatin cell killing effects in resistant and sensitive NSCLC cell lines via p53-dependent and -independent apoptotic pathways

Gangduo Wang, Jinshun Zhao, Xiping Li, Hong Ding, Cynthia Cunningham, Daniel Flynn, Eddie Reed, Qingdi Q. Li

Cancer Res (2005) 65 (9_Supplement): 972–973.

Published: 01 May 2005

View article

Journal Articles

Protein phosphatase 2A interacts with Chk2 and regulates its phosphorylation at thr-68 after cisplatin treatment of human ovarian cancer cells

Xiaobing Liang, Jing Jie Yu, Eddie Reed

Cancer Res (2005) 65 (9_Supplement): 1309.

Published: 01 May 2005

View article

Journal Articles

Elemene augments 5-fluorouracil sensitivity in cyclooxygenase-2-expressing colon cancer cells through a mitochondria-mediated apoptotic pathway

Hong Ding, Gangduo Wang, Xiping Li, Jinshun Zhao, Daniel C. Flynn, Eddie Reed, Qingdi Q. Li

Cancer Res (2005) 65 (9_Supplement): 1353.

Published: 01 May 2005

View article

Journal Articles

Elemene and cisplatin synergistically induce apoptosis in chemoresistant ovarian carcinoma cells

Xiping Li, Cynthia Cunningham, Gangduo Wang, Jinshun Zhao, Hong Ding, Daniel C. Flynn, Eddie Reed, Qingdi Q. Li

Cancer Res (2005) 65 (9_Supplement): 410–411.

Published: 01 May 2005

View article

Journal Articles

Chk2 activation by Thr-68 phosphorylation is regulated by p53 in response to cisplatin treatment in human ovarian cancer cells

Jing Jie Yu, Xiaobing Liang, Heimo Riedel, Eddie Reed

Cancer Res (2005) 65 (9_Supplement): 715–716.

Published: 01 May 2005

View article

NARROW

Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer.

Abstract LB-223: A specific Isoform of Gli1 binds the promoter region of c-fos in A2780-CP70 human ovarian cancer cells.

Abstract 771: Changes in the subcellular pharmacology of cisplatin, in response to treatment of cells with an anti-Gli1 shRNA

Abstract 605: Olive polyphenol, hydroxytyrosol, exerts anti-tumor effects in prostate cancer cells by targeting Akt, STAT3 and AR signaling

Abstract 834: Inhibition of Gli1 results in altered c-jun activation, inhibition of cisplatin-induced up-regulation of ERCC1, XPD, and XRCC1, and inhibition of platinum-DNA adduct repair

Abstract 3991: Protein phosphatase 2A (PP2A) downregulation is associated with androgen-independent and aggressive phenotypes in prostate cancer

Abstract 5613: A specific isoform of Gli1 binds the Gli-binding site of the c-jun and c-fos promoters

Abstract 3406: Understanding molecular pathway differences between ovarian cancer stem cells (OCSC) and non-ovarian cancer stem cells (non-OCSC) leads to the Hedgehog pathway as a common thread

Abstract 249: Inhibition of protein phosphatase 2A supports androgen-independent growth of prostate cancer cells

Abstract 2156: c-Myb promotes growth, invasion and androgen-independence of prostate cancer cells

Abstract LB-281: Inhibition of Hedgehog results in altered regulation of c-jun and of ERCC1 in cisplatin-resistant A2780-CP70 human ovarian cancer cells

A Gynecologic Oncology Group Study of Platinum-DNA Adducts and Excision Repair Cross-Complementation Group 1 Expression in Optimal, Stage III Epithelial Ovarian Cancer Treated with Platinum-Taxane Chemotherapy

Variant DNA repair genes occur infrequently in African Americans: Implications for different clinic response to platinum chemotherapy

Fanconi anemia D2 protein confers chemoresistance and contributes to S phase cell cycle arrest in response to the anticancer agent, irofulven

MZF1 possesses a repressively regulatory function in ERCC1 expression

Elemene, a novel plant anticancer drug, enhances cisplatin cell killing effects in resistant and sensitive NSCLC cell lines via p53-dependent and -independent apoptotic pathways

Protein phosphatase 2A interacts with Chk2 and regulates its phosphorylation at thr-68 after cisplatin treatment of human ovarian cancer cells

Elemene augments 5-fluorouracil sensitivity in cyclooxygenase-2-expressing colon cancer cells through a mitochondria-mediated apoptotic pathway

Elemene and cisplatin synergistically induce apoptosis in chemoresistant ovarian carcinoma cells

Chk2 activation by Thr-68 phosphorylation is regulated by p53 in response to cisplatin treatment in human ovarian cancer cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only